(1) Bausch Health Companies Inc (NYSE:BHC) triggered: 09/19/2019
Bausch Health Companies is a pharmaceutical and medical device company. Co. has four segments: Bausch + Lomb/International, which consists of pharmaceutical, over-the-counter and medical device products, with a focus on the Vision Care, Surgical, Consumer and Ophthalmology Rx products; Salix, which consists of gastroenterology products; Ortho Dermatologics, which consists of Ortho Dermatologics (dermatological) products, and Solta medical aesthetic devices; and Diversified Products, which consists of pharmaceutical products in the areas of neurology and certain other therapeutic classes, the U.S. of generic products, the U.S. of dentistry products and of certain other businesses.
BHC — last trade: $22.86 — Recent Insider Buys:
William D. Humphries
Joseph C. Papa
CHAIRMAN & CEO
BHC — Key Stats (updated Friday, September 20, 10:18 AM)
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.